Patents by Inventor Deborah A. Paul

Deborah A. Paul has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PDE9 inhibitors for treating sickle cell disease
    Patent number: 12213975
    Abstract: The present disclosure relates to PDE9 inhibitors, pharmaceutical compositions comprising the PDE9 inhibitors, and methods of using the PDE9 pharmaceutical compositions for the treatment of sickle cell disease (SCD).
    Type: Grant
    Filed: February 26, 2021
    Date of Patent: February 4, 2025
    Assignee: Cardurion Pharmaceuticals, Inc.
    Inventors: Edward George Calamai, Deborah Lynn Leithead Dobbins, Michael Paul Dehart, James McArthur, Shi Yin Foo
  • HEV orf-2 monoclonal antibodies and methods for using same
    Patent number: 5830636
    Abstract: Monoclonal antibodies are described which specifically bind to Hepatitis E Virus (HEV), and more particularly to HEV orf-2 antigen. Also provided are hybridoma cell lines which secrete these monoclonal antibodies, methods for using these monoclonal antibodies, and assay kits which contain these monoclonal antibodies.
    Type: Grant
    Filed: February 22, 1996
    Date of Patent: November 3, 1998
    Assignee: Abbott Laboratories
    Inventors: Deborah A. Paul, Mark F. Knigge
  • Mouse monoclonal antibodies to Hepatitis E virus and methods for using same
    Patent number: 5667966
    Abstract: Monoclonal antibodies are described which specifically bind to Hepatitis E Virus (HEV), and more particularly to HEV orf-3 antigen. Also provided are hybridoma cell lines which secrete these monoclonal antibodies, methods for using these monoclonal antibodies, and assay kits which contain these monoclonal antibodies.
    Type: Grant
    Filed: August 22, 1996
    Date of Patent: September 16, 1997
    Assignee: Abbott Laboratories
    Inventors: Deborah A. Paul, Mark F. Knigge
  • Immunoassay for HTLV-III antigens
    Patent number: 4748110
    Abstract: The invention is a diagnostic immunoassay which detects human T-cell lymphotropic virus-III (HTLV-III) antigen. The immunoassay utilizes a sandwich assay technique and the addition of a labeled second antibody to increase sensitivity. The second antibody is from an animal species different from the first.
    Type: Grant
    Filed: September 25, 1985
    Date of Patent: May 31, 1988
    Assignee: Abbott Laboratories
    Inventor: Deborah A. Paul